Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Hess

Showing results (131-140 of 217) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2008
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancerCornelia Liedtke, Chafika Mazouni, Kenneth R Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast CancerCornelia Liedtke, Chafika Mazouni, Kenneth R Hess, et al.
Cancer Journal (Sudbury, Mass.)|December 26, 2002
Global gene expression changes during neoadjuvant chemotherapy for human breast cancerThomas A Buchholz, David N Stivers, James Stec, et al.
The Lancet. Oncology|October 6, 2009
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialEric L Chang, Jeffrey S Wefel, Kenneth R Hess, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgeryGarrett Jensen, Chad Tang, Kenneth R Hess, et al.
Advances in Radiation Oncology|June 13, 2020
Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and ObservationStephen R Grant, Xiudong Lei, Kenneth R Hess, et al.
Oncotarget|August 4, 2016
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trialsJ Andrew Livingston, Kenneth R Hess, Aung Naing, et al.
BMC Cancer|May 20, 2020
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBCToshiaki Iwase, Kenichi Harano, Hiroko Masuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium studyKurt A Jaeckle, Kenneth R Hess, W K Alfred Yung, et al.
Oncotarget|July 13, 2015
Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trialsIshwaria M Subbiah, Gerald S Falchook, Ahmed O Kaseb, et al.
Pageof 22

Showing results (131-140 of 217) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2008
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancerCornelia Liedtke, Chafika Mazouni, Kenneth R Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast CancerCornelia Liedtke, Chafika Mazouni, Kenneth R Hess, et al.
Cancer Journal (Sudbury, Mass.)|December 26, 2002
Global gene expression changes during neoadjuvant chemotherapy for human breast cancerThomas A Buchholz, David N Stivers, James Stec, et al.
The Lancet. Oncology|October 6, 2009
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialEric L Chang, Jeffrey S Wefel, Kenneth R Hess, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgeryGarrett Jensen, Chad Tang, Kenneth R Hess, et al.
Advances in Radiation Oncology|June 13, 2020
Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and ObservationStephen R Grant, Xiudong Lei, Kenneth R Hess, et al.
Oncotarget|August 4, 2016
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trialsJ Andrew Livingston, Kenneth R Hess, Aung Naing, et al.
BMC Cancer|May 20, 2020
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBCToshiaki Iwase, Kenichi Harano, Hiroko Masuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium studyKurt A Jaeckle, Kenneth R Hess, W K Alfred Yung, et al.
Oncotarget|July 13, 2015
Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trialsIshwaria M Subbiah, Gerald S Falchook, Ahmed O Kaseb, et al.
Pageof 22